Stock CUV CLINUVEL PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Clinuvel Pharmaceuticals Limited

Equities

CUV

AU000000CUV3

Delayed Australian S.E.
Other stock markets
 11:54:34 2024-05-01 pm EDT 		5-day change 1st Jan Change
15.02 AUD -0.27% Intraday chart for Clinuvel Pharmaceuticals Limited +0.87% -6.12%
Apr. 29 Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% MT
Mar. 14 Clinuvel Pharmaceuticals Launches Share Buyback Program MT

Evolution of the average Target Price on Clinuvel Pharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

ecfe4262.R2EHQk3a07Pzb2Q0ilKw2x7GqSbEtrMg3FRRiGxTPiw.f1hvJyi9pt_EDDxGwn_4kFqWnUWBw9hGpB9n0BY0WnsjDHYbPZHn3acqUA~3711407c5dd41db3d14fcc450bb54c35

Analyst Recommendations on Clinuvel Pharmaceuticals Limited

Morgans Financial Upgrades Clinuvel Pharmaceuticals to Add From Hold; Price Target is AU$16 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
15.06 AUD
Average target price
25.6 AUD
Spread / Average Target
+70.00%
High Price Target
46.3 AUD
Spread / Highest target
+207.44%
Low Price Target
16 AUD
Spread / Lowest Target
+6.24%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Clinuvel Pharmaceuticals Limited

Morgans Financial

Ratings for Clinuvel Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CUV Stock
  4. Consensus Clinuvel Pharmaceuticals Limited